
Benzinga Pro data, Agilon Health (NYSE:AGL) reported Q4 sales of $462.89 million. Earnings fell to a loss of $56.74 million, resulting in a 57.79% decrease from last quarter. Agilon Health collected $458.61 million in revenue during Q3, but reported earnings showed a $35.96 million loss.